Certain Balance Sheet Accounts - Additional Information (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Feb. 17, 2023	Dec. 31, 2022
Property, Plant and Equipment [Line Items]
Intangible assets, net	$ 2,253,000		$ 2,253,000			$ 2,279,000
Accumulated amortization	236,000		236,000			206,000
Capitalized software development costs	1,873,000		1,873,000
Capitalized computer software, amortization	0	$ 0	0	$ 0
Impairment of intangible assets, finite-lived	0	0	0	0
Accrued sales return current	$ 1,717,000		$ 1,717,000			$ 6,756,000
Series A Convertible Preferred Stock
Property, Plant and Equipment [Line Items]
Temporary equity, shares authorized (in shares)	10,741,071		10,741,071			10,741,071
Temporary equity, par value (in dollars per share)	$ 0.0001		$ 0.0001			$ 0.0001
Temporary equity, shares issued (in shares)	30,000		30,000		30,000	0
Customers For Which Returns Are Expected To Be Received
Property, Plant and Equipment [Line Items]
Accrued sales returns resulting from FDA Warning Letter	$ 36,000		$ 36,000			$ 4,958,000
Tooling and manufacturing equipment
Property, Plant and Equipment [Line Items]
Depreciation and amortization expense	148,000	208,000	330,000	398,000
Property and Equipment
Property, Plant and Equipment [Line Items]
Depreciation and amortization expense	$ 225,000	$ 320,000	$ 500,000	$ 629,000